ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
SOTIO Announces Clinical Collaboration with MSD to Evaluate IL-15 Superagonist, SOT101, in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors
December 09, 2021SOTIO Biotech, a clinical stage immuno-oncology company owned by PPF Group, announced today that it has entered into a clinical trial collaboration and supply agreement with MSD... -
SOTIO Secures €280m of Funding to Expand and Advance Clinical Pipeline
December 03, 2021SOTIO Biotech, a clinical stage immuno-oncology company owned by PPF Group, announced today that is has secured €280m of funding to significantly expand and advance its clinical pipeline, including its lead asset SOT101...
Pharma Sources Insight January 2025
